申请人:Bayer Aktiengesellschaft
公开号:US04002763A1
公开(公告)日:1977-01-11
Antimycotic compositions are produced which comprise an antimycotically effective amount of a 1,2,4-triazole of the formula: ##STR1## or a pharmaceutically acceptable non-toxic salt thereof wherein X.sup.1 is hydrogen or alkyl; X.sup.2 is hydrogen or alkyl; R.sup.1 is alkyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl; R.sup.2 is hydrogen, alkyl or unsubstituted or substituted aryl; R.sup.3 is alkyl, cycloalkyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl; and Y is a keto group of a functional derivative of a keto group, in combination with a pharmaceutically acceptable non-toxic, inert diluent or carrier.
生产抗真菌组合物,包括具有下列式中的1,2,4-三唑的抗真菌有效量:##STR1## 或其药学上可接受的非毒性盐,其中X^1为氢或烷基;X^2为氢或烷基;R^1为烷基,未取代或取代的芳基或未取代或取代的芳基烷基;R^2为氢,烷基或未取代或取代的芳基;R^3为烷基,环烷基,未取代或取代的芳基或未取代或取代的芳基烷基;Y为酮基或酮基的功能衍生物,与药学上可接受的非毒性、惰性稀释剂或载体结合。